Joe Barton

I want to commend the committee staff, both the majority and minority.

But I think the methane emissions rules would be very bad for the oil and gas industry in Texas...

To his credit, President Obama said he wanted to do.

You have killed the coal industry, basically. Killed it.

To protect public health and the environment, implementing the laws that Congress has passed.

It is our job to pass a law and yours to implement it.

Well, the point I am trying to make is the estimates that were used when we passed the expanded RFS in 2007 were gasoline volumes and diesel volumes going up, and in fact they are not.

I supported it then. I was ranking member when they passed the 2007 Energy Bill that greatly expanded it, and I have vehemently opposed the expansion in committee and on the floor.

More government bureaucracy, regulations, and spending never successfully reduced the price of health care.

The number one complaint people have about health care is the rising cost.

The Affordable Care Act is not the health reform this country needed. In fact, I believe it is a setback.

We need better options so patients can truly own a plan of their choosing on the individual market.

We are tying them to a monitor that they may never have been around.

Can I tell the difference? If I breathe air right now, can I tell the difference between 70 parts per billion and 75 parts per billion?

I want to be clear, I am not trying to ask the FCC to shut down the Internet but I do think that in an open society you can strike a balance between openness and protecting the public good.

NNSA was a management experiment gone wrong.

It makes it very difficult to ask her tough questions when she is so polite and receptive to my input.

I wish that Congresswoman Eshoo was a member of the subcommittee because, while I know a little bit about this, Anna is really the expert on this issue.

It looks to me like we have two issues here. We have an FDA issue, you are right, seeing Ms. Woodcock.

I cannot overstate the importance of treating each biosimilar individually rather than as if they were a generic drug.

This approach undermines the real intent of the legislation.

We all agree that it is important for FDA to get it right, but most of us think it is also time for FDA to get on down the road.

Six years ago, I co-authored, along with Congresswoman Anna Eshoo, the Biologics Price Competition and Innovation Act.

Thank you for your leadership. I am going to have to excuse myself, but thank you for this Special Order.

I have got an insurance premium that is higher than I have ever paid in my life.